Checkpoint Therapeutics, Inc. (CKPT) earnings
CKPT earnings moved a median of +2.67% by the close. Quarterly and annual CKPT reports and results, each read against the price at its own news timestamp. Back to the CKPT overview →
11 measured CKPT earnings events.
Where these CKPT earnings landedvs 11 measured CKPT earnings reactions
| Middle 50% of CKPT earnings reactions | -0.32% to +4.32% |
|---|---|
| Median reaction (to close) | +2.67% |
| Measured reactions | 11 |
Point-in-time · zero look-ahead
Half of the 11 CKPT earnings events with a measured close landed between -0.32% and +4.32%; 64% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Checkpoint Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.24% | +0.00% | |
| Form 10-K Checkpoint Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -0.37% | +0.25% | |
| Checkpoint Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Updates | Press release | -0.58% | +5.85% | |
| Form 10-Q Checkpoint Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.58% | +5.85% | |
| Checkpoint Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Updates | Press release | -0.89% | +2.67% | |
| Form 10-Q Checkpoint Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -1.70% | -5.08% | |
| Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates | Press release | -0.64% | -4.46% | |
| Form 10-Q Checkpoint Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -0.65% | -0.65% | |
| Form 10-K Checkpoint Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +1.43% | +4.17% | |
| Checkpoint Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights | Press release | +2.70% | +4.32% | |
| Form 10-Q Checkpoint Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +2.70% | +4.32% |
Keep exploring
More CKPT: analyst actions → · SEC filings → · CKPT overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Axsome Therapeutics, Inc. (AXSM) | 391 | +0.05% | 52% |
| RA PHARMACEUTICALS (RARX) | 391 | -0.04% | 45% |
| Select Medical Holdings Corporation (SEM) | 387 | -0.03% | 41% |
| PhaseBio Pharmaceuticals, Inc. (PHAS) | 385 | 0.00% | 48% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.